nesvacumab

With Novartis closing in, Regeneron scraps Eylea combo drug in a major setback
Endpoints
Mon, 11/27/17 - 09:18 am
Novartis
Regeneron
Eylea
RTH258
nesvacumab
Bayer
Regeneron and Bayer To Jointly Develop Novel Combination Therapy for Eye Diseases
Yahoo
Thu, 03/24/16 - 09:56 am
Bayer
Regeneron
eye disease
nesvacumab
Aflibercept